Elevar Therapeutics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 46

Employees

  • Latest Deal Type
  • Debt - PPP

Elevar Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to elevate treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. The company is engaged in developing two proprietary drug candidates that have demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with the potential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent, enabling patients to get a new way to treat disease.

Contact Information

Formerly Known As
Lifecord International
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • One Bridge Plaza North
  • Suite 850
  • Fort Lee, NJ 07024
  • United States
+1 (801)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • One Bridge Plaza North
  • Suite 850
  • Fort Lee, NJ 07024
  • United States
+1 (801)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elevar Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - PPP 15-Apr-2020 Completed Generating Revenue
4. Merger/Acquisition 18-Oct-2019 Completed Generating Revenue
3. Later Stage VC 09-May-2019 Completed Generating Revenue
2. Later Stage VC 31-Jul-2018 $20M $20M Completed Generating Revenue
1. Secondary Transaction - Private 29-Aug-2014 $2M Completed Generating Revenue
To view Elevar Therapeutics’s complete valuation and funding history, request access »

Elevar Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to elevate treatment experiences and outcomes for patients who have lim
Drug Discovery
Fort Lee, NJ
46 As of 2025

Plymouth Meeting, PA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elevar Therapeutics Competitors (3)

One of Elevar Therapeutics’s 3 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
AVEO Oncology Formerly VC-backed Boston, MA
Celldex Formerly VC-backed Hampton, NJ
You’re viewing 3 of 3 competitors. Get the full list »

Elevar Therapeutics Patents

Elevar Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019094832-A1 A combination therapy with apatinib for the treatment of cancer Inactive 10-Nov-2017

Elevar Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elevar Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Paratus Investment PE/Buyout Minority
To view Elevar Therapeutics’s complete investors history, request access »

Elevar Therapeutics Investments & Acquisitions (3)

Elevar Therapeutics’s most recent deal was a Corporate Asset Purchase with Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) for . The deal was made on 25-Mar-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) 25-Mar-2020 Corporate Asset Purchase Buildings and Property
Joint Venture (Neopharma / Elevar Therapeutics) 25-Oct-2019 Merger/Acquisition Distributors (Healthcare)
LSK Global PS 01-Jan-2001 Merger/Acquisition BPO/Outsource Services
To view Elevar Therapeutics’s complete investments and acquisitions history, request access »

Elevar Therapeutics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
LSK Global PS Seoul, South Korea 2000

Elevar Therapeutics FAQs

  • When was Elevar Therapeutics founded?

    Elevar Therapeutics was founded in 2005.

  • Where is Elevar Therapeutics headquartered?

    Elevar Therapeutics is headquartered in Fort Lee, NJ.

  • What is the size of Elevar Therapeutics?

    Elevar Therapeutics has 46 total employees.

  • What industry is Elevar Therapeutics in?

    Elevar Therapeutics’s primary industry is Drug Discovery.

  • Is Elevar Therapeutics a private or public company?

    Elevar Therapeutics is a Private company.

  • What is Elevar Therapeutics’s current revenue?

    The current revenue for Elevar Therapeutics is .

  • How much funding has Elevar Therapeutics raised over time?

    Elevar Therapeutics has raised $40M.

  • Who are Elevar Therapeutics’s investors?

    Paratus Investment has invested in Elevar Therapeutics.

  • Who are Elevar Therapeutics’s competitors?

    Inovio Pharmaceuticals, AVEO Oncology, and Celldex are competitors of Elevar Therapeutics.

  • When was Elevar Therapeutics acquired?

    Elevar Therapeutics was acquired on 15-Apr-2020.

  • Who acquired Elevar Therapeutics?

    Elevar Therapeutics was acquired by HLB (Holding Companies).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process